Sanofi will acquire Vigil for its oral small molecule TREM2 project, dubbed VG-3927, that is on tap for a Phase 2 in ...

GSK’s blockbuster respiratory drug Nucala was approved Thursday for certain patients with chronic obstructive pulmonary ...

FDA Commissioner Marty Makary defended thousands of staff cuts during his first congressional hearing since taking office, ...

The White House released its first MAHA Commission report, detailing some of the Trump administration’s top priorities for ...

First sale rule allows pharma companies to reduce tariff duties by declaring lower drug values at US customs, as industry ...

Cigna on Wednesday said it negotiated with Novo Nordisk and Eli Lilly to secure deeper GLP-1 drug discounts for employers ...

Hinge Health prices IPO at $32/share, valuing company at $3B. CEO Daniel Perez's firm to trade as HNGE on NYSE, raising ...

Endpoints News announces URL change from endpts.com to endpoints.news effective June 1, 2025, with legacy redirects planned ...

Venrock's Healthcare Prognosis survey shows 71% favor AI integration in existing companies over new AI firms, with mixed ...

After a median 34.2 months of follow-up, patients taking Itovebi in combination with Pfizer’s Ibrance and AstraZeneca’s Faslodex survived for a median of 34 months, compared to 27 months for those ...

Self-guided mental health programs and digital therapeutics like Headspace, DaylightRx save money, while virtual therapy from Lyra, Talkspace costs more ...

FDA names Elizabeth Miller as acting associate commissioner of OII; J&J's Wolk emphasizes tax reform for US manufacturing; ...